BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Finnish Biotech NADMED Secures €3.5M to Transform Vitamin B3 Testing with Groundbreaking NAD Measurement Technology

Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fre...

August 23, 2024 | News

Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development

Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...

August 19, 2024 | News

Rona Therapeutics Secures $35 Million Series A+ Financing to Advance siRNA Programs

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 M...

July 22, 2024 | News

Merck Group Announces Acquisition of UnitySC for €155 Million

This strategic acquisition is a significant milestone in Merck’s Electronics business, aimed at expanding its capabilities and strengthening ...

July 18, 2024 | News

Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...

June 25, 2024 | News

Ascentage Pharma Announces Completion of Equity Investment by Takeda

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related...

June 21, 2024 | News

HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...

May 29, 2024 | News

AstraZeneca Announces $1.5 Billion Manufacturing Facility in Singapore for Cutting-Edge Cancer Treatments

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...

May 20, 2024 | News

Nabla Bio Secures $26 Million Series A and $550 Million in Strategic Pharma Collaborations

➢ Company builds integrated AI and wet lab technologies to design developable, selective, and functionally active protein drugs against ...

May 15, 2024 | News

Allozymes Secures $15 Million Series A Funding to Transform Enzyme Engineering and Expand Global Presence

Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Se...

May 15, 2024 | News

NSG BioLabs Secures $14.5 Million Investment, Expands Partnerships to Bolster Singapore's Biotech Ecosystem

NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investme...

May 08, 2024 | News

Gilead Sciences Invests US$4 Million in Global Fight Against Viral Hepatitis

Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant World Hepatitis Allianc...

April 16, 2024 | News

D3 Bio Secures $62M in Series A+ Financing for Cancer Drug Development

D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs announces its cl...

April 09, 2024 | News

Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline

Johnson & Johnson (NYSE: JNJ) announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...

March 08, 2024 | News

Stay Connected